Team Structure headcount by department
How to prospect Feno By Niox® Usa's departments
Sales
This is where the company's largest headcount sits (5 people). Sales leaders respect good selling: a sharp, well-researched approach is your best credential.
General Management
The company's second-largest department (1 people). General management thinks in strategic priorities: link your value proposition to one of theirs or you will not get a reply.
Other
1 people work in this department. Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.
FAQ Feno By Niox® Usa
Who runs Feno By Niox® Usa?
The highest-ranking leadership role identified at Feno By Niox® Usa is “Director”, based on public data updated 18 Oct 2026.
How many decision makers does Feno By Niox® Usa have?
1 decision maker identified.
How do I contact a decision maker at Feno By Niox® Usa?
Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.
Companies similar to Feno By Niox® Usa
More companies to explore
Medical Equipment Manufacturing · United States
-
Envista Holdings Corporation 5,000 employees
-
Coopercompanies 10,001 employees
-
Jabil Healthcare 50 employees
All Medical Equipment Manufacturing companies in United States →
About Feno By Niox® Usa
Feno By Niox® Usa is a business specialised in Medical Equipment Manufacturing, based in United States. Founded in 2006, the company counts about 500 employees. Within the wider Manufacturing sector, Feno By Niox® Usa focuses on the Medical Equipment Manufacturing segment. Its customer base is mainly professional: Feno By Niox® Usa operates on a B2B model. Sales teams can rely on this profile to qualify Feno By Niox® Usa, spot business signals, and connect with verified decision makers.
Activity & Market
The company evolves in the Medical Equipment Manufacturing segment of the Manufacturing sector. As a B2B company, Feno By Niox® Usa primarily serves business clients and professional organisations. The company is categorised as “Public company”.